Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00199628|
Recruitment Status : Unknown
Verified September 2005 by University Hospital, Limoges.
Recruitment status was: Recruiting
First Posted : September 20, 2005
Last Update Posted : March 13, 2006
Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.
The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.
The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.
|Condition or disease|
|Glomerulonephritis, Membranous Neonatal Diseases and Abnormalities Hemochromatosis|
|Study Type :||Observational|
|Enrollment :||100 participants|
|Observational Model:||Defined Population|
|Official Title:||Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|
|Study Start Date :||September 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00199628
|Contact: Vincent Guigonis, MD||+33(0)555 056 firstname.lastname@example.org|
|Limoges University Hospital||Recruiting|
|Limoges, France, 87042|
|Contact: Vincent Guigonis, MD +33(0) 555 056 358 email@example.com|
|Principal Investigator: Vincent Guigonis, MD|
|Principal Investigator:||Vincent Guigonis, MD||Department of Pediatrics, Limoges University Hospital|